Hypertension Diagnostics, Inc.
HDII · OTC
3/31/2023 | 9/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | – | – | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | $0 | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | -$0 | – |
| % Margin | – | – | – | – |
| Net Income | – | – | -$0 | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | -0.003 | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | -$0 |
| Capital Expenditures | – | – | – | $0 |
| Free Cash Flow | – | – | – | -$0 |